Evaluation of haematological inflammatory ratios in migraine: a systematic review and meta-analysis
- 1Department of Neurology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Bielanski Hospital
- 2Sadyba Medical Center
Abstract
Haematological inflammatory ratios, including the neutrophil-to-lymphocyte ratio (NLR), have emerged as potential biomarkers in various neurological disorders. This systematic review and meta-analysis aimed to evaluate these ratios in patients with migraine compared with healthy controls and other headache disorders, and to assess differences across migraine subtypes and clinical phases. The systematic review with meta-analysis was conducted according to the PRISMA guidelines. PubMed (MEDLINE), Web of Science, Scopus, the Cochrane Library, MEDLINE Ultimate, and Embase were searched from their inception to 26 April 2025. Additionally, backward and forward citation searches were performed. Risk of bias was assessed using the Newcastle–Ottawa Scale. Random-effects models employing the DerSimonian–Laird method and Hartung–Knapp adjustment were used to estimate pooled mean values with 95% confidence intervals. Heterogeneity was quantified with the I² and Cochran’s Q tests. Publication bias was assessed using funnel plots and Begg’s test. Twenty-three studies met the inclusion criteria, and 21 were included in the meta-analysis. The pooled mean NLR was significantly higher in patients with migraine compared to healthy controls, particularly in those with migraine with aura and during the ictal phase. No significant differences were found between migraine and tension-type headache. Other ratios showed no significant intergroup differences. Substantial heterogeneity and the observational design of included studies were noted as limitations. Among the evaluated ratios, the NLR appeared to most consistently reflect inflammatory processes in migraine, especially in migraine with aura and during the ictal period. However, its clinical utility remains uncertain and further studies are needed to clarify their potential role as diagnostic and prognostic biomarkers. PROSPERO registration: CRD420251041190. No external funding was received.
Related
- Integrated haematological, inflammatory and endothelial biomarkers in steady-state and vaso-occlusive crisis of sickle cell disease: a case-control study in Benin City
- Leukocyte-to-HDL Ratios for Symptomatic Phenotyping in Heart Failure: Head-to-Head Comparison of Routine Inflammatory Indices and Benchmarking Against NT-proBNP
- Can Dietary Supplements Improve Inflammatory Biomarkers and Clinical Symptoms in Migraine? A Narrative Review
- Global prevalence of vancomycin-resistant Enterococcus in patients with haematological malignancies: a systematic review and meta-analysis
- Clinical Phenotypes, Neuroimaging, and Outcomes in Prolonged and Persistent Non-Motor Migraine Aura: A Systematic Review and Episode-Level Synthesis
BibTeX
@article{sochan2026evaluation,
title = {{Evaluation of haematological inflammatory ratios in migraine: a systematic review and meta-analysis}},
author = {Patryk Sochań and Olga Grodzka and Patrycja J. Sochań and Katarzyna Kępczyńska and Izabela Domitrz},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-72777-4},
url = {https://doi.org/10.1038/s41598-026-72777-4},
note = {CC BY},
}
RIS
TY - JOUR
TI - Evaluation of haematological inflammatory ratios in migraine: a systematic review and meta-analysis
AU - Patryk Sochań
AU - Olga Grodzka
AU - Patrycja J. Sochań
AU - Katarzyna Kępczyńska
AU - Izabela Domitrz
PY - 2026
DA - 2026/09/01
JO - Scientific Reports
DO - 10.1038/s41598-026-72777-4
UR - https://doi.org/10.1038/s41598-026-72777-4
AB - Haematological inflammatory ratios, including the neutrophil-to-lymphocyte ratio (NLR), have emerged as potential biomarkers in various neurological disorders. This systematic review and meta-analysis aimed to evaluate these ratios in patients with migraine compared with healthy controls and other headache disorders, and to assess differences across migraine subtypes and clinical phases. The systematic review with meta-analysis was conducted according to the PRISMA guidelines. PubMed (MEDLINE), Web of Science, Scopus, the Cochrane Library, MEDLINE Ultimate, and Embase were searched from their inception to 26 April 2025. Additionally, backward and forward citation searches were performed. Risk of bias was assessed using the Newcastle–Ottawa Scale. Random-effects models employing the DerSimonian–Laird method and Hartung–Knapp adjustment were used to estimate pooled mean values with 95% confidence intervals. Heterogeneity was quantified with the I² and Cochran’s Q tests. Publication bias was assessed using funnel plots and Begg’s test. Twenty-three studies met the inclusion criteria, and 21 were included in the meta-analysis. The pooled mean NLR was significantly higher in patients with migraine compared to healthy controls, particularly in those with migraine with aura and during the ictal phase. No significant differences were found between migraine and tension-type headache. Other ratios showed no significant intergroup differences. Substantial heterogeneity and the observational design of included studies were noted as limitations. Among the evaluated ratios, the NLR appeared to most consistently reflect inflammatory processes in migraine, especially in migraine with aura and during the ictal period. However, its clinical utility remains uncertain and further studies are needed to clarify their potential role as diagnostic and prognostic biomarkers. PROSPERO registration: CRD420251041190. No external funding was received.
SN - 2045-2322
ER -